Gong-Ling Peng1, Liang Li2, Ya-Wen Guo3, Pan Yu3, Xing-Jie Yin3, Shan Wang3, Chun-Ping Liu3. 1. Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, China. 2. Department of Radiology, Renmin Hospital of Wuhan University Wuhan 430060, China. 3. Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430000, China.
Abstract
BACKGROUND: There is conflicting evidence regarding the prognostic value of cytotoxic T cell infiltration in breast cancer. The aims of this study were to detect the expression levels and localization of FoxP3 and CD8 in invasive ductal carcinoma of the breast and to investigate the correlations among FoxP3+ regulatory T cells (Tregs), CD8+ cytotoxic T lymphocytes (CTLs), clinicopathological features, and prognosis in patients with breast cancer. METHODS: Immunohistochemistry was used to detect the expression levels and localization of FoxP3 and CD8. One-sample t-test, one-way analysis of variance, and Kaplan-Meier log-rank tests were used to analyze correlations between the expression levels of CD8 and FoxP3; Kaplan-Meier Log-rank test was used to analyze clinicopathological features to explore the prognostic significance of CD8 and FoxP3 in patients with breast cancer. RESULTS: FoxP3 expression in the tumor bed was higher than that in the stroma, while CD8 was primarily expressed in the stroma. CD8 expression was associated with favorable prognostic factors. However, FoxP3 expression and an increased ratio of total FoxP3+ Tregs to CD8+ CTLs were significantly correlated with unfavorable prognostic factors. Additionally, an increased ratio was associated with molecular subtypes (ER+Her2+, ER+Her2-, ER-Her2+, and ER-Her2-) of breast cancer. Overexpression of FoxP3 and a high FoxP3+/CD8+ ratio were correlated with poor overall survival (OS) and disease-free survival (DFS). However, CD8 expression only affected OS in patients with breast cancer. CONCLUSIONS: Tumor-infiltrating lymphocytes are localized variously depending on the subtype. CD8+ CTLs were associated with a good prognosis, while FoxP3+ Tregs were associated with adverse outcomes in patients with breast cancer. CD8+ CTLs and FoxP3+ Tregs are potential predictive prognostic factors for patients with breast cancer.
BACKGROUND: There is conflicting evidence regarding the prognostic value of cytotoxic T cell infiltration in breast cancer. The aims of this study were to detect the expression levels and localization of FoxP3 and CD8 in invasive ductal carcinoma of the breast and to investigate the correlations among FoxP3+ regulatory T cells (Tregs), CD8+ cytotoxic T lymphocytes (CTLs), clinicopathological features, and prognosis in patients with breast cancer. METHODS: Immunohistochemistry was used to detect the expression levels and localization of FoxP3 and CD8. One-sample t-test, one-way analysis of variance, and Kaplan-Meier log-rank tests were used to analyze correlations between the expression levels of CD8 and FoxP3; Kaplan-Meier Log-rank test was used to analyze clinicopathological features to explore the prognostic significance of CD8 and FoxP3 in patients with breast cancer. RESULTS:FoxP3 expression in the tumor bed was higher than that in the stroma, while CD8 was primarily expressed in the stroma. CD8 expression was associated with favorable prognostic factors. However, FoxP3 expression and an increased ratio of total FoxP3+ Tregs to CD8+ CTLs were significantly correlated with unfavorable prognostic factors. Additionally, an increased ratio was associated with molecular subtypes (ER+Her2+, ER+Her2-, ER-Her2+, and ER-Her2-) of breast cancer. Overexpression of FoxP3 and a high FoxP3+/CD8+ ratio were correlated with poor overall survival (OS) and disease-free survival (DFS). However, CD8 expression only affected OS in patients with breast cancer. CONCLUSIONS:Tumor-infiltrating lymphocytes are localized variously depending on the subtype. CD8+ CTLs were associated with a good prognosis, while FoxP3+ Tregs were associated with adverse outcomes in patients with breast cancer. CD8+ CTLs and FoxP3+ Tregs are potential predictive prognostic factors for patients with breast cancer.
Entities:
Keywords:
CD8; FoxP3; breast cancer; tumor bed; tumor stroma
Authors: Sahar M A Mahmoud; Emma Claire Paish; Desmond G Powe; R Douglas Macmillan; Matthew J Grainge; Andrew H S Lee; Ian O Ellis; Andrew R Green Journal: J Clin Oncol Date: 2011-04-11 Impact factor: 44.544
Authors: Kristi Baker; Jonathan Lachapelle; Inti Zlobec; Tarek A Bismar; Luigi Terracciano; William D Foulkes Journal: Histopathology Date: 2011-06-24 Impact factor: 5.087
Authors: C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs Journal: Nat Genet Date: 2001-01 Impact factor: 38.330
Authors: Anne C Knol; Jean M Nguyen; Gaëlle Quéreux; Anabelle Brocard; Amir Khammari; Brigitte Dréno Journal: Exp Dermatol Date: 2011-03-16 Impact factor: 3.960
Authors: Jared E Lopes; Troy R Torgerson; Lisa A Schubert; Stephanie D Anover; Elizabeth L Ocheltree; Hans D Ochs; Steven F Ziegler Journal: J Immunol Date: 2006-09-01 Impact factor: 5.422
Authors: Linda Hertlein; Thomas Kolben; Aurelia Vattai; Nadine Kremer; Sarah Meister; Susanne Beyer; Lucia Keilmann; Anna Hester; Mina Temelkov; Helene Heidegger; Elisa Schmoeckel; Mirjana Kessler; Sven Mahner; Udo Jeschke Journal: J Cancer Res Clin Oncol Date: 2021-11-05 Impact factor: 4.553
Authors: Gregor Manukian; Charles Kivolowitz; Tiziana DeAngelis; Anuradha A Shastri; Jason E Savage; Kevin Camphausen; Ulrich Rodeck; Jelani C Zarif; Nicole L Simone Journal: Int J Radiat Oncol Biol Phys Date: 2021-02-26 Impact factor: 8.013
Authors: Melissa A Gray; Michal A Stanczak; Natália R Mantuano; Han Xiao; Johan F A Pijnenborg; Stacy A Malaker; Caitlyn L Miller; Payton A Weidenbacher; Julia T Tanzo; Green Ahn; Elliot C Woods; Heinz Läubli; Carolyn R Bertozzi Journal: Nat Chem Biol Date: 2020-08-17 Impact factor: 15.040